Awareness of Family Physicians about HPV and Prevention Methods

Author :  

Year-Number: 2021-1
Yayımlanma Tarihi: 2021-04-19 00:53:26.0
Language : English
Konu :
Number of pages: 27-35
Mendeley EndNote Alıntı Yap

Abstract

Keywords

Abstract

Aim: In this study we aimed to determine the knowledge level of family physicians about Human Papilloma Virus (HPV) infection and HPV vaccines.

Methods: A total of 208 resident physicians working in the Department of Family Medicine were included in the study. Each participant was asked to fill out an HPV awareness questionnaire, which consisted of 22 questions. In cases where family physicians did not recommend HPV vaccines, the reasons were noted.

Results: The median age was 29 years. A total of 207 of the participants (67.4%) stated that they advised HPV vaccines. Among the family medicine resident physicians, “don’t know” as a response to questions about general information regarding HPV was between 0.3-5.8 percent. The most common reasons not to recommend the vaccine were lack of knowledge (17.4%), the vaccine not being in the schedule of the Health Ministry (16.1%) and the high cost (15.8%).

Conclusions: The findings obtained in our study show that the level of knowledge of resident physicians on HPV infections, cervical cancer and HPV vaccines and their support rate for HPV vaccines were inadequate. For better protection from HPV, family physicians should be better informed about the disease.

Keywords


  • 1. Koutsky LA, Kiviat NB. Genital HumanPapillomavirus. In: Holmes KK, Sparling PF, Mårdh PA,et al, eds. Sexually Transmitted Diseases. 3rd ed. New York: McGraw Hill; 2013:347-59.

  • 2. Şahiner F, Şener K. Human Papilloma VirüsEnfeksiyonları, Risk Faktörleri ve Koruyucu Önlemler.TAF Preventive Medicine Bulletin. 2013; 12(6): 715-3. Cilingir IU, Bengisu E, Ağaçfidan A, et al. Microarraydetection of human papilloma virus genotypes amongTurkish women with abnormal cytology at acolposcopy unit. J Turk Ger Gynecol Assoc 2013 14:23-4. Maglennon GA, Doorbar J. The biology ofpapillomavirus latency. Open Virol J. 2012;6:190-7.

  • 5. Beutner KR. Nongenital human papillomavirus infections. Clin Lab Med. 2000;20(2):423.

  • 6. Carr J, Gyorfi T, Human papillomavirus.Epidemiology, transmission, and pathogenesis. Clin Lab Med. 2000;20(2):235.

  • (Accessed on April 27, 2012).

  • 8. Kanbur AGA, Çapık YDDC. Servikal KanserdenKorunma, Erken Tanı-Tarama Yöntemleri veEbe/Hemşirenin Rolü. Hacettepe ÜniversitesiHemşirelik Fakültesi Dergisi. 2011; 18(1): 061- 072.

  • 9. Schiffman M, Wentzensen N, Wacholder S, KinneyW, Gage JC, Castle PE. Human papillomavirus testingin the prevention of cervical cancer. J Natl Cancer Inst. 2011 Mar;103(5):368-83.

  • 10. Markowitz LE, Liu G, Hariri S, Steinau M, DunneEF, Unger ER. Prevalence of HPV After Introduction ofthe Vaccination Program in the United States. Pediatrics. 2016;137(3):e20151968.

  • 11. Cocchio S, Bertoncello C, Baldovin T, Fonzo M,Bennici SE, Buja A, Majori S, Baldo V. Awareness ofHPV and drivers of HPV vaccine uptake amonguniversity students: A quantitative, cross-sectionalstudy. Health Soc Care Community. 2020;28(5):1514- 1524. doi: 10.1111/hsc.12974.

  • 12. Donati S, Giambi C, Declich S, Salmaso S, Filia A,Ciofi degli Atti ML, Alibrandi MP, Brezzi S, Carozzi F,Collina N, Franchi D, Lattanzi A, Meda M, Minna MC,Nannini R, Gallicchio G, Bella A; PreGio Working group.Knowledge, attitude and practice in primary andsecondary cervical cancer prevention among youngadult Italian women. Vaccine. 2012;30(12):2075-82. doi: 10.1016/j.vaccine.2012.01.057.

  • 13. Schmidt-Grimminger D, Frerichs L, Black Bird AE,Workman K, Dobberpuhl M, Watanabe-Galloway S.HPV knowledge, attitudes, and beliefs among NorthernPlains American Indian adolescents, parents, youngadults, and health professionals. J Cancer Educ.2013;28(2):357-66. doi: 10.1007/s13187-013- 0468-y.14. Almughais ES, Alfarhan A, Salam M. Awareness ofprimary health care physicians about human papillomavirus infection and its vaccination: a cross- sectionalsurvey from multiple clinics in Saudi Arabia. InfectDrug Resist. 2018;11:2257-2267. doi: 10.2147/IDR.S179642.

  • 15. Anfinan NM. Physician's knowledge and opinionson human papillomavirus vaccination: a cross-sectionalstudy, Saudi Arabia. BMC Health Serv Res.2019;19(1):963. doi: 10.1186/s12913-019-4756-z.

  • 16. Naki MM, Celik H, Api O, Toprak S, Ozerden E,Unal O. Awareness,knowledge and attitudes related toHPV infection and vaccine among non-obstetrician-gynecologist healthcare providers. J Turk Ger Gynecol Assoc.2010;11(1):16-21.

  • 17. Abi Jaoude J, Saad H, Farha L, Dagher H, Khair D,Kaafarani MA, Jamaluddine Z, Cherfan P. Barriers,Attitudes and clinical approach of lebanese physicianstowards HPV vaccination; a cross- sectional study.Asian Pac J Cancer Prev. 2019;20(10):3181-3187. doi: 10.31557/APJCP.2019.20.10.3181.

  • 18. Kops NL, Hohenberger GF, Bessel M, CorreiaHorvath JD, Domingues C, Kalume Maranhão AG,Alves de Souza FM, Benzaken A, Pereira GF,Wendland EM. Knowledge about HPV and vaccinationamong young adult men and women: Results of anational survey. Papillomavirus Res. 2019;7:123- 128. doi: 10.1016/j.pvr.2019.03.003.

  • 19. Adıguzel FI, Adıguzel C, Seyfettinoglu S,Hurriyetoglu S, Kazgan H, Saygili- Yilmaz ES, Yucel O,Baser E. HPV awareness and HPV vaccine acceptanceamong women who apply to the gynecology outpatientclinics at a tertiary referral hospital in the southMediterranean region of Turkey. Bakırköy Tıp Dergisi. 2016;12:136-9. doi: 10.5350/BTDMJB201612306

  • 20. Saylam-Kurtipek G, Göksin-Cihan F, Özer I, Can-Turhan Z. The knowledge, attitude and behaviours ofwomen above 18 years old about genital warts,cervical cancer and human papilloma virus vaccination.Turk J Dermatol. 2016;10:105-9. doi: 10.4274/tdd.2894

  • 21. Oz M, Cetinkaya N, Apaydin A, Korkmaz E, Bas S,Ozgu1 E, Gungor T. Awareness and knowledge levelsof Turkish college students about Human PapillomaVirus infection and vaccine acceptance. J Cancer Educ.2018;33(2):260-268. doi:10.1007/s13187-016-1116-0

  • 22. Adjei Boakye E, Tobo BB, Rojek RP, MohammedKA, Geneus CJ, Osazuwa- Peters N. Approaching adecade since HPV vaccine licensure: Racial and genderdisparities in knowledge and awareness of HPV andHPV vaccine. Hum Vaccin Immunother.2017;13(11):2713-2722. doi: 10.1080/21645515.2017.1363133.

  • 23. Grigore M, Teleman SI, Pristavu A, Matei M.Awareness and Knowledge About HPV and HPVVaccine Among Romanian Women. J Cancer Educ.2018;33(1):154-159. doi: 10.1007/s13187-016-1130-24. Kaya-Şenol D. How Much I Am Aware of HumanPapilloma Virus (HPV)? TJFMPC. 2019;13(4):462-71. doi: 10.21763/tjfmpc.651359

  • 25. Dursun P, Kuşçu E, Zeyneloğlu HB, Yanık FB,Ayhan A. Maternal Factors affecting HPV VaccineAcceptance for their adolescent children aged between10 and 15. Turk J Obstet Gynecol. 2009;6(3):206-210.26. Lin W, Wang Y, Liu Z, Chen B, Yuan S, Wu B, GongL. Inequalities in Awareness and Attitude towards HPVand Its Vaccine between Local and Migrant ResidentsWho Participated in Cervical Cancer Screening inShenzhen, China. Cancer Res Treat. 2020;52(1):207- 217. doi: 10.4143/crt.2019.053.

  • 27. Görkem Ü, Toğrul C, İnal HA, Salman-Özgü B,Güngör T. Knowledge and attitudes of allied healthpersonnel in university hospital related to HumanPapilloma Virus and the vaccine. Turk Hij Den BiyolDerg. 2015;72(4):303-10. doi: 10.5505/TurkHijyen.2015.35556.

  • 28. Sherman SM, Bartholomew K, Denison HJ, Patel H,Moss EL, Douwes J, Bromhead C. Knowledge, attitudesnd awareness of the human papillomavirus amonghealth professionals in New Zealand. PLoS One.2018;13(12):e0197648. doi: 10.1371/journal.pone.0197648.

  • 29. Khamisy-Farah R, Adawi M, Jeries-Ghantous H,Bornstein J, Farah R, Bragazzi NL, Odeh M. Knowledgeof Human Papillomavirus (HPV), Attitudes andPractices owards Anti-HPV Vaccination Among IsraeliPediatricians, Gynecologists, and Internal MedicineDoctors: Development and Validation of an Ad HocQuestionnaire. Vaccines (Basel). 2019;7(4):157. doi: 10.3390/vaccines7040157.

  • 30. Singh J, Roy B, Yadav A, Siddiqui S, Setia A,Ramesh R, Singh K. Cervical cancer awareness andHPV vaccine acceptability among females in Delhi: Across-sectional study. Indian J Cancer. 2018;55(3):233-237. doi: 10.4103/ijc.IJC_28_18.

  • 31. Korfage IJ, Essink-Bot ML, Daamen R, Mols F, vanBallegooijen M. Women show mixed intentionsregarding the uptake of HPV vaccinations in pre-adolescents: a questionnaire study. Eur J Cancer.2008;44(9):1186-92. doi: 10.1016/j.ejca.2008.03.018.32. Dursun P, Altuntas B, Kuscu E, Ayhan A. Women'sknowledge about human papillomavirus and theiracceptance of HPV vaccine. Aust N Z J ObstetGynaecol. 2009;49(2):202-6. doi: 10.1111/j.1479- 828X.2009.00947.x.

                                                                                                                                                                                                        
  • Article Statistics